" My client was placed at a considerable competitive disadvantage as a result of his use of Mifrin , " Farber ' s lawyer , Alexander J . Willmer , said . " He is being made to suffer merely because of a lack of good judgment in painkiller brand decision making , a matter entirely unrelated to his ability to do the job . My client and I believe it is the responsibility of Mifrin and its parent corporation , Global Tetrahedron Pharmaceuticals , to offer appropriate compensatory reparations . "
